Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Calcified Tissue International|November 15, 2012
A novel monthly dosing regimen of risedronate for the treatment of postmenopausal osteoporosis: 2-year dataMichael R McClung, Claude-Laurent Benhamou, Zulema Man, et al.
Nonlinearity in Biology, Toxicology, Medicine|March 31, 2009
The use of streptolysin o for the treatment of scars, adhesions and fibrosis: initial investigations using murine models of sclerodermaStephen W Mamber, Vit Long, Ryan G Rhodes, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2014
Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohortVéronique Breuil, Patricia Panaia-Ferrari, Eric Fontas, et al.
Bone|October 9, 2007
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosisPierre D Delmas, Michael R McClung, José R Zanchetta, et al.
Obstetrics and Gynecology|July 2, 2013
Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trialChris Recknor, Edward Czerwinski, Henry G Bone, et al.
Stem Cells (Dayton, Ohio)|June 28, 2008
Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosisChristian Elabd, Armelle Basillais, Hélène Beaupied, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 7, 2011
Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosisMichael R McClung, Steven Boonen, Ove Törring, et al.
Joint Bone Spine|April 30, 2015
Trabecular Bone Score: Where are we now?Valérie Bousson, Catherine Bergot, Bruno Sutter, et al.
Joint Bone Spine|April 8, 2014
Usefulness of bone density measurement in fallersHubert Blain, Yves Rolland, Olivier Beauchet, et al.
Pageof 9